NeuroBo Pharmaceuticals, Inc. – NASDAQ:NRBO
NeuroBo Pharmaceuticals stock price today
$2.36
-2.64
-52.8%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 25 minutes
NeuroBo Pharmaceuticals stock price monthly change
+30.21%
month
NeuroBo Pharmaceuticals stock price quarterly change
+28.54%
quarter
NeuroBo Pharmaceuticals stock price yearly change
+1087.65%
year
NeuroBo Pharmaceuticals key metrics
Market Cap | 20.33M |
Enterprise value | N/A |
P/E | -0.04 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.07 |
PEG ratio | N/A |
EPS | -3.27 |
Revenue | N/A |
EBITDA | -23.31M |
Income | -16.58M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuroBo Pharmaceuticals stock price history
NeuroBo Pharmaceuticals stock forecast
NeuroBo Pharmaceuticals financial statements
| Jun 2023 | 0 | -734K | |
|---|---|---|---|
| Sep 2023 | 0 | -3.81M | |
| Dec 2023 | 4K | -5.31M | -132850% |
| Mar 2024 | 0 | -6.71M |
| 2025 | 7K | -30.03M | -429028.57% |
|---|---|---|---|
| 2026 | 7K | -34.44M | -492047.57% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 29179000 | 3.98M | 13.65% |
|---|---|---|---|
| Sep 2023 | 26425000 | 4.87M | 18.45% |
| Dec 2023 | 22781000 | 6.09M | 26.76% |
| Mar 2024 | 17018000 | 6.94M | 40.79% |
| Jun 2023 | -2.04M | 0 | -80 |
|---|---|---|---|
| Sep 2023 | -2.81M | -37K | 0 |
| Dec 2023 | -3.39M | -9K | 0 |
| Mar 2024 | -6.44M | -5K | 0 |
NeuroBo Pharmaceuticals alternative data
| Aug 2023 | 2 |
|---|---|
| Sep 2023 | 2 |
| Oct 2023 | 2 |
| Nov 2023 | 2 |
| Dec 2023 | 2 |
| Jan 2024 | 2 |
| Feb 2024 | 2 |
| Mar 2024 | 2 |
| Apr 2024 | 2 |
| May 2024 | 8 |
| Jun 2024 | 8 |
| Jul 2024 | 8 |
NeuroBo Pharmaceuticals other data
2.29%
-97.71%
of NRBO is owned by hedge funds
59.05K
-1.33M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 5089060 | 0 |
| Patent |
|---|
Application Filling date: 15 Oct 2021 Issue date: 3 Feb 2022 |
Application Filling date: 8 Feb 2021 Issue date: 16 Sep 2021 |
Application Filling date: 13 Nov 2020 Issue date: 6 May 2021 |
Grant Utility: Composition containing mixed extract of mulberry and Poria cocos bark for preventing, improving or treating neurodegenerative disorders Filling date: 16 Mar 2020 Issue date: 16 Mar 2021 |
Grant Filling date: 3 Dec 2015 Issue date: 15 Dec 2020 |
Application COMPOSITION CONTAINING MIXED EXTRACT OF MULBERRY AND PORIA COCOS BARK FOR PREVENTING, IMPROVING OR TREATING NEURODEGENERATIVE DISORDERS Filling date: 16 Mar 2020 Issue date: 17 Sep 2020 |
Application GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Filling date: 17 Oct 2019 Issue date: 13 Aug 2020 |
Grant Filling date: 29 Jun 2018 Issue date: 14 Jul 2020 |
Grant Filling date: 3 Dec 2015 Issue date: 17 Mar 2020 |
-
What's the price of NeuroBo Pharmaceuticals stock today?
One share of NeuroBo Pharmaceuticals stock can currently be purchased for approximately $2.36.
-
When is NeuroBo Pharmaceuticals's next earnings date?
Unfortunately, NeuroBo Pharmaceuticals's (NRBO) next earnings date is currently unknown.
-
Does NeuroBo Pharmaceuticals pay dividends?
No, NeuroBo Pharmaceuticals does not pay dividends.
-
How much money does NeuroBo Pharmaceuticals make?
NeuroBo Pharmaceuticals has a market capitalization of 20.33M.
-
What is NeuroBo Pharmaceuticals's stock symbol?
NeuroBo Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "NRBO".
-
What is NeuroBo Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NeuroBo Pharmaceuticals?
Shares of NeuroBo Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does NeuroBo Pharmaceuticals have?
As Jul 2024, NeuroBo Pharmaceuticals employs 8 workers, which is 300% more then previous quarter.
-
When NeuroBo Pharmaceuticals went public?
NeuroBo Pharmaceuticals, Inc. is publicly traded company for more then 9 years since IPO on 5 Aug 2016.
-
What is NeuroBo Pharmaceuticals's official website?
The official website for NeuroBo Pharmaceuticals is neurobopharma.com.
-
Where are NeuroBo Pharmaceuticals's headquarters?
NeuroBo Pharmaceuticals is headquartered at 200 Berkeley Street, Boston, MA.
-
How can i contact NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals's mailing address is 200 Berkeley Street, Boston, MA and company can be reached via phone at 857 702 9600.
NeuroBo Pharmaceuticals company profile:
NeuroBo Pharmaceuticals, Inc.
neurobopharma.comExchange:
NASDAQ
Full time employees:
8
Industry:
Biotechnology
Sector:
Healthcare
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
200 Berkeley Street
Boston, MA 02116
Boston, MA 02116
CIK: 0001638287
ISIN: US64132R4048
CUSIP: 64132R107
